Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Novozymes

Novozymes
PUBLIC STATUS
5K-10K EMPLOYEES
NZYM B STOCK SYMBOL
27 INVESTMENTS
$48.77 SHARE PRICE (As of Tuesday Closing)
Description

Novozymes is the world leader in industrial enzymes. In recent years, the company has expanded into micro-organisms, primarily for agricultural markets. The firm supplies five major industry groups: household care, food and beverages, bioenergy, agriculture and feed, and technical and pharma. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark.

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Stock Exchange
CSE
Primary Office
  • Krogshoejvej 36
  • 2880 Bagsvaerd
  • Denmark

+45 44 00 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Novozymes’s full profile, request a free trial.

Novozymes Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$39.52 - $49.58 $13.7B $49.48 $1.62 460K 281M

Novozymes Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 12,536,044 13,208,056 16,918,460 10,684,179
Revenue 2,169,613 2,277,854 2,202,631 2,100,485
EBITDA 584,074 783,556 748,206 724,966
Net Income 463,784 510,657 472,783 453,011
Total Assets 2,953,072 3,017,384 2,960,808 2,640,248
Total Debt 634,371 499,093 366,455 255,124
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Novozymes Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Novozymes‘s full profile, request access.

Request full access to PitchBook

Novozymes Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Amyris Corporate Backed or Acquired Emeryville, CA 000 00.000 000000 - 000 00.000
000000 00000000 Venture Capital-Backed Boston, MA 000 00000 00000000000 00000
000 0000 000 00000 Corporate Backed or Acquired York, United Kingdom 000 0000 000000000000 0000
000000 Venture Capital-Backed Seattle, WA 00 000.00 0000000000 0 000.00
0000000 Private Debt Financed Nicholasville, KY 0000 00000 000000000 00 00000
To view this company’s complete list of competitors, request access »

Novozymes Investments & Acquisitions (27)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000000 13-Dec-2018 00000 00000 00 00.00 Agricultural Chemicals
00000000 000000 (0 04-Apr-2017 000000000 00000 Buildings and Property
0000000000000 15-Sep-2016 000000000000000000 Biotechnology 000000000 0ø0000000
0000000000000 02-Dec-2015 00000 00000 00 00.000 Agricultural Chemicals
Pacific Vet Group- USA 05-Oct-2015 Merger/Acquisition Biotechnology 00000 000000 0000000
To view this company’s complete investment and acquisition history, request access »

Novozymes Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000 00000000000 01-Jul-2001 000000000000000000 Completed
  • 000000000
To view this company’s complete exits history, request access »

Novozymes Subsidiaries (6)

Company Name Industry Location Founded
Pacific Vet Group- USA Biotechnology Fayetteville, AR 2008
0000000000000 Biotechnology Berlin, Germany 0000
00000000 Food Products Sombreffe, Belgium 0000
000000 00000000000 Drug Discovery Adelaide, Australia 0000
00 000000000000 Agricultural Chemicals Watertown, SD 0000
To view this company’s complete subsidiary history, request access »

Novozymes Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Novozymes‘s full profile, request access.

Request full access to PitchBook

Novozymes Executive Team (38)

Name Title Board
Seat
Contact
Info
Peder Holk Nielsen Ph.D President & Chief Executive Officer
Ten Melnik President, Novozymes Biologicals
Prisca Havranek-Kosicek Ph.D Executive Vice President & Chief Financial Officer
Thomas Videbæk Ph.D Executive Vice President and Chief Operating Officer for Research, Innovation and Supply
Sebastian Søderberg Business Development and Marketing Director

22 Former Executives

You’re viewing 5 of 38 executives. Get the full list »

Novozymes Board Members (3)

Name Representing Role Since Contact
Info
000000 0ü00000 Self Chairman 000 0000
0000000 000é0 00.0 Self Board Member 000 0000

1 Former Board Member

You’re viewing 2 of 3 board members. Get the full list »